Geoffrey L. Ahern, MD, PhD

Department of Neurology - Faculty

Geoff Ahern, MD, PhD Geoffrey L. Ahern, MD, PhD
Professor of Neurology, Psychology and Psychiatry
Professor, Evelyn F. McKnight Brain Institute
Director, Behavioral Neuroscience and Alzheimer's Clinic
Senior Investigator, Arizona Alzheimer's Disease Core Center (ADCC) - UAHSC Clinical Core Center


Education/Training:

  • BS: SUNY at Purchase, 1976
  • MS: Yale University, 1978
  • PhD: Yale University, 1981
  • MD: Yale University, 1984
  • Internship: Waterbury Hospital, 1984-85
  • Residency: Boston University, 1985-88
  • Fellowship (Behavioral Neurology): Beth Israel Hospital / Harvard Medical School, 1988-90
  • Board Certification: Neurology, American Board of Psychiatry and Neurology; Behavioral Neurology & Neuropsychiatry, United Council for Neurological Subspecialties

Clinical/Research Interests:

Behavioral Neurology; Dementia; Alzheimer's Disease; Wada Test; Paraneoplastic Syndromes; Cerebral Lateralization for Emotional Processes; Quantitative EEG; Psychophysiology

Original Papers:

  1. Ahern GL, Landin ML, and Wolf G. Escape from deficits in sodium intake after thalamic lesions as a function of preoperative experience. Journal of Comparative and Physiological Psychology, 1978, 92, 544-554.
  2. Ahern GL and Schwartz GE. Differential lateralization for positive versus negative emotion. Neuropsychologia, 1979, 17, 693-698.
  3. Schwartz GE, Ahern GL, and Brown, SL. Lateralized facial muscle response to positive and negative emotional stimuli. Psychophysiology, 1979, 16, 561-571.
  4. Schwartz GE, Brown SL, and Ahern GL. Facial muscle patterning and subjective experience during affective imagery. Sex differences. Psychophysiology, 1980, 17, 75-82.
  5. Ahern GL and Schwartz GE. Differential lateralization for positive versus negative emotion in the human brain. EEG spectral analysis. Neuropsychologia, 1985, 23, 745-755.
  6. Ahern GL, Howard GF, and Weiss K. Posttraumatic pilomotor seizures. A case report. Epilepsia, 1988, 29, 640-643.
  7. Daffner KR, Ahern GL, Weintraub SW, and Mesulam MM. Dissociated neglect behavior following sequential strokes in the right hemisphere. Annals of Neurology, 1990, 28, 97-101.
  8. , Schomer DL, Kleefield J, Blume H, Cosgrove GR, Weintraub S, and Mesulam MM. Right hemisphere advantage for evaluating emotional facial expressions. Cortex, 1991, 27, 193-202.
  9. Ahern GL, Herring AM, Tackenberg J, Seeger JF, Oommen KJ, Labiner DM, and Weinand ME. The association of multiple personality and temporolimbic epilepsy. Intracarotid sodium amobarbital test observations. Archives of Neurology, 1993, 50, 1020-1025.
  10. Weinstein CS, Seidman LJ, and Ahern GL. Integration of neuropsychological and behavioral neurologic assessment in psychiatry: A case study. Psychiatry, 1994, 57, 62-76.
  11. Ahern GL, Herring AM, Tackenberg JN, Schwartz GE, Seeger JF, Labiner DM, Weinand ME, and Oommen KJ. Affective self-report during the intracarotid sodium amobarbital test. Journal of Clinical and Experimental Neuropsychology, 1994, 16(3), 372-376.
  12. Ahern GL, O'Connor M, Dalmau J, Coleman A, Posner JB, Schomer DL, Herzog AG, Kolb DA, and Mesulam MM. Paraneoplastic temporal lobe epilepsy with testicular neoplasm and atypical amnesia. Neurology, 1994, 44, 1270-1274.
  13. Ahern GL, Labiner DM, Hutzler R, Osburn C, Talwar D, Herring AM, Tackenberg JN, Weinand ME, and Oommen KJ. Quantitative analysis of the EEG in the intracarotid amobarbital test. I. Amplitude analysis. EEG & Clinical Neurophysiology, 1994, 91, 21-32.
  14. Tackenberg JN, Ahern GL, Herring AM, and Hutzler R. Nursing implications of the intracarotid amobarbital procedure. Journal of Neuroscience Nursing, 1994, 26, 309-318.
  15. Weinand ME, Hermann B, Wyler AR, Carter LP, Oommen KJ, Labiner DM, Ahern GL, and Herring AM. Long-term subdural strip electrocorticographic monitoring of ictal déjà vu. Epilepsia, 1994, 35, 1054-1059.
  16. Ahern GL. Cerebral laterality and consciousness: Letter in reply to Serafetinides. Archives of Neurology, 1995, 52, 337-338.
  17. Ahern GL, Labiner DM, Talwar D, Herring AM, and Weinand ME. Quantitative analysis of the EEG in the intracarotid amobarbital test. II. Coherence analysis. Journal of Clinical Neurophysiology, 1995, 12, 285-290.
  18. , O'Connor M, Dalmau J, Coleman A, Posner JB, Schomer DL, Herzog AG, Kolb DA, and Mesulam MM. Paraneoplastic temporal lobe epilepsy with testicular neoplasm and atypical amnesia. Search on Epilepsy, 1995, 2, 20-24.
  19. Weinand ME, El-Saadany W, Labiner DM, Talwar D, and Ahern GL. Subdural strip electrode monitoring and surgical decision making in refractory epilepsy. Validity and prognostic value of noninvasive localizing data. Journal of Epilepsy, 1995, 8, 131-138.
  20. Weinand ME, Carter LP, Oommen KJ, Hutzler R, Labiner DM, Talwar D, El-Saadany W, and Ahern GL. Response of human epileptic temporal lobe cortical blood flow to hyperventilation. Epilepsy Research, 1995, 21, 221-226.
  21. Weinand ME, El-Saadany W, Carter LP, Labiner DM, Oommen KJ, Talwar D, and Ahern GL. Temporal lobe ischemia and epileptogenicity. Long-term cortical cerebral blood flow analysis of sequential seizures. Surgical Forum, 1995, 46, 574-575.
  22. Weintraub SW, Daffner, KR, Ahern GL, Price BH, and Mesulam MM. Right hemispatial neglect and bilateral cerebral lesions. Journal of Neurology, Neurosurgery, and Psychiatry, 1996, 60, 342-344.
  23. Tackenberg JN and Ahern GL. Anatomic correlates of psychological events related to temporolimbic epilepsy. Journal of Neuroscience Nursing, 1996, 28, 73-81.
  24. Weinand ME, El-Saadany WF, Labiner DM, Carter LP, Oommen KJ, Talwar D, and Ahern GL. Abnormal vasomotor response of human epileptogenic cortex to reversal of hyperventilation: A long-term surface cerebral blood flow monitoring study. Pathophysiology, 1996, 3, 41-45.

  25. Reiman EM, Lane RD, Ahern GL, Schwartz GE, Davidson RJ, Friston KJ, Yun LS, and Chen K. Neuroanatomical correlates of externally and internally generated human emotion. American Journal of Psychiatry, 1997, 154, 918-925.
  26. Lane RD, Reiman EM, Ahern GL, Schwartz GE, and Davidson RJ. Neuroanatomical correlates of happiness, sadness, and disgust. American Journal of Psychiatry, 1997, 154, 926-933.
  27. Lane RD, Reiman EM, Bradley MM, Lang PJ, Ahern GL, Davidson RJ, and Schwartz GE. Neuroanatomical correlates of positive and negative emotion. Neuropsychologia, 1997, 35, 1437-1444
  28. Lane RD, Ahern GL, Schwartz GE, and Kaszniak AW. Is alexithymia the emotional equivalent of blindsight. Biological Psychiatry, 1997, 42, 834-844.
  29. O’Connor M, Sieggreen MA, Ahern GL, Schomer D, and Mesulam MM. Accelerated forgetting in association with temporal lobe epilepsy and paraneoplastic encephalitis. Brain and Cognition, 1997, 35, 71-84.
  30. Ahern GL, Herring AM, Labiner DM, and Weinand ME. Quantification of hemispatial neglect during the intracarotid amytal procedure. Journal of the International Neuropsychological Society, 1998, 4, 1-7.
  31. Weinand ME, Takacs I, Labiner DM, and Ahern GL. Nonepileptic cortical cerebral blood flow and temporal lobe epileptogenicity. Pathophysiology, 1999, 6, 135-141.
  32. Ahern GL, Herring AM, Labiner DM, Weinand ME, and Hutzler R. Affective self-report during the intracarotid sodium amobarbital test: Group differences. Journal of the International Neuropsychological Society, 2000, 6, 659-667.
  33. Weinand ME, Deogaonkar M, Kester M, Ahern GL, and Labiner DM. Electrocorticographic factors associated with temporal lobe epileptogenicity. Pathophysiology, 2000, 7, 33-39.
  34. Weinand ME, Labiner DM, and Ahern GL. Temporal lobe seizure interhemispheric propagation time depends on nonepileptic cortical cerebral blood flow. Epilepsy Research, 2001, 44, 33-39.
  35. Ahern GL, Sollers J, Lane RD, Labiner DM, Herring AM, Weinand ME, Hutzler R, and Thayer J. Heart rate and heart rate variability changes in the intracarotid sodium amobarbital (ISA) test. Epilepsia, 2001, 42, 912-921.
  36. Weinand ME, Kester M, Labiner DM, and Ahern GL. Time from ictal subdural EEG seizure onset to clinical seizure onset: Prognostic value for selecting temporal lobectomy candidates. Neurological Research, 2001, 23, 599-604.
  37. Weinand ME, Labiner DM, and Ahern GL. Integration of perceptual and mnemonic dysfunction: Sensory auras are associated with left hemispheric memory impairment. Epilepsy & Behavior, 2001, 2, 423-432.
  38. Labiner DM and Ahern GL. Neurologic consultation for seizures. When, why, and how to pursue. Postgraduate Medicine, 2002, 111(1), 53-64.
  39. Sollers JJ, Ahern GL, Merritt MM, and Thayer JF. Time frequency analysis of the cardiovascular response during the intracarotid amobarbital test. Biomedical Sciences Instrumentation, 2002, 38, 267-271.
  40. Labiner DM, Weinand ME, Brainerd CJ, Ahern GL, Herring AM, and Melgar M. Prognostic value of concordant seizure focus localizing data in the selection of temporal lobectomy candidates. Neurological Research, 2002, 24, 747-755.
  41. Gonzalez-Portillo G, Rivero S, Ahern GL, Labiner DM, and Weinand ME. Normalization of periictal bihemispheric cerebral perfusion in temporal lobe epilepsy. Pathophysiology, 2004, 11, 31-34.
  42. Torres MR, Ahern GL, and Labiner DM. Seizures and Epilepsy. An approach to diagnosis and management.  Journal of Clinical Outcomes Management, 2005, 12(2), 103-113.
  43. Rogers J, Li R, Mastroeni D, Grover A, Leonard B, Ahern G, Cao P, Kolody H, Vedders L, Kolb WP, Sabbagh M. Peripheral clearance of amyloid β peptide by complement C3-dependent adherence to erythrocytes. Neurobiology of Aging, 2006, 27, 1733-1739.
  44. Weinand ME, Hussain N, Labiner DM, and Ahern GL. Correlation of electrocorticographic to clinical seizure onset and interhemispheric propagation times in temporal lobe epilepsy. Pathophysiology, 2006, 13, 233-236.
  45. Valla J, Schneider L, Niedzielko T, Coon K, Caselli R, Sabbagh M, Ahern GL, Baxter L, Alexander G, Walker DG, and Reiman EM. Impaired platelet mitochondrial activity in Alzheimer’s disease and Mild Cognitive Impairment. Mitochondrion, 2006, 6, 323-330.
  46. Labiner DM and Ahern, GL.  Vagus nerve stimulation (VNS) therapy in pharmacoresistant epilepsy and treatment-resistant depression: Therapeutic parameter settings. Acta Neurologica Scandinavica, 2007, 115, 23-33.
  47. Weinand ME, Farley C, Hussain N, Labiner DM, and Ahern GL. Time from ictal subdural EEG seizure onset to clinical seizure onset: An electrocorticographic factor associated with temporal lobe epileptogenicity.Neurological Research, 2007, 29(8), 862-870.
  48. Thayer JF, Sollers JJ, Labiner DM, Weinand ME, Herring AM, Lane RD, and Ahern GL. Age related differences in prefrontal control of heart rate in humans: A pharmacological blockade study. International Journal of Psychophysiology, 2009, 72(1), 81-88.
  49. Lane RD, McRae KL, Reiman EM, Chen K, Ahern GL, Thayer JF.  Neural correlates of heart rate variability during emotion. NeuroImage, 2009, 44, 214-223.
  50. Weinand M, Serxner B, Labiner D, Ahern GL. Interhemispheric propagation time and temporal lobe epileptogenicity. Pathophysiology, 2009, 16, 39-42.
  51. Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, Locke DEC, Snyder CH, Alexander GE, Rademakers R, Reiman EM. Longitudinal modeling of age-related memory decline and the APOE ε4 effect. New England Journal of Medicine, 2009, 361(3), 255-263.
  52. Caselli RJ, Dueck AC, Locke DEC, Sabbagh MN, Ahern GL, Rapcsak SZ, Baxter LC, Yaari R, Woodruff BK, Snyder CH, Rademakers R, Findley S, Reiman EM. Cerebrovascular risk factors influence preclinical memory decline in cognitively normal APOE ε4 homozygotes. Neurology, 2011, 76, 1078-1084.

Study Group Publications

  1. Rogers SL, Friedhoff LT, and the Donepezil Study Group (incl. Ahern GL). The efficacy and safety of donepezil in patients with Alzheimer’s disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial. Dementia, 1996, 7, 293-303.

  2. Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka, Gulanski B, and the Metrifonate Study Group (incl. Ahern GL). Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer’s disease. Neurology, 1998, 50, 1222-1230.

  3. Tariot PN, Solomon PR, Morris JC, Kershaw P, Lilienfeld S, Ding C, and the Galantamine Study Group (incl. Ahern GL). A 5-month, randomized, placebo-controlled trial of galantamine in AD. Neurology, 2000, 54, 2269-2276.
  4. Sacco RL, DeRosa JT, Haley EC, Levin B, Ordronneau P, Phillips SJ, Rundek R, Snipes RG, Thompson JLP, and the GAIN Americas Investigators (incl. Ahern GL). Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: A randomized controlled trial. Journal of the American Medical Association, 2001, 285(13), 1719-1728.
  5. Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MF, Jin S, Thomas RG, Thal LJ, for the Alzheimer’s Disease Cooperative Study (incl. Ahern GL). Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: A randomized controlled trial. Journal of the American Medical Association, 2003, 289(21), 2819-2826.
  6. Grundman M, Jack CR, Petersen RC, Kim HT, Taylor C, Datvian M, Weiner MF, DeCarli C, DeKosky ST, van Dyck C, Darvesh S, Yaffe K, Kaye J, Ferris SH, Thomas RG, and Thal LJ, for the Alzheimer’s Disease Cooperative Study (incl. Ahern GL). Hippocampal volume is associated with memory but not nonmemory cognitive performance in patients with mild cognitive impairment. Journal of Molecular Neuroscience, 2003, 20, 241-248.

  7. Jack CR, Slomkowski M, Gracon S, Hoover TM, Felmlee JP, Stewart K, Xu Y, Shiung M, O’Brien PC, Cha R, Knopman D, Petersen RC, and the Milameline Study Group (incl. Ahern GL). MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology, 2003, 60(2), 253-260.
  8. Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, and Thal LJ, for the Alzheimer’s Disease Cooperative Study (incl. Ahern GL). A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease. Sleep, 2003, 26(7), 893-901.

  9. Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, and Thal LJ, for the Alzheimer’s Disease Cooperative Study (incl. Ahern GL). Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Archives of Neurology, 2004, 61, 59-66.

  10. Fleisher AS, Grundman M, Jack CR., Petersen RC, Taylor C, Kim HT, Schiller DHB, Bagwell V, Sencakova D, Weiner MF, DeCarli C, DeKosky ST, van Dyck CH, and Thal LJ, for the Alzheimer’s Disease Cooperative Study Group (incl. Ahern GL). Sex, apolipoprotein E ε4 status, and hippocampal volume in mild cognitive impairment. Archives of Neurology, 2005, 62, 953-957.

  11. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, and Thal LJ, for the Alzheimer’s Disease Cooperative Study Group (incl. Ahern GL). Vitamin E and donepezil for the treatment of mild cognitive impairment. New England Journal of Medicine, 2005, 352, 1-10.

  12. Fleisher AS, Sowell, BB, Taylor C, Gamst AC, Petersen RC, and Thal LJ, for the Alzheimer’s Disease Cooperative Study Group (incl. Ahern GL). Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.. Neurology, 2007, 68(19), 1588-1595.

  13. Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, and Thal LJ, for the Alzheimer’s Disease Cooperative Study Group (incl. Ahern GL). High-dose B vitamin supplementation and cognitive decline in Alzheimer Disease: A randomized controlled trial. Journal of the American Medical Association, 2008, 300(15), 1774-1783.

  14. Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, Jack CR, Aisen PS, and Thal LJ, for the Alzheimer’s Disease Cooperative Study Group (incl. Ahern GL). Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology, 2008, 70(3), 191-199.

  15. Jack CR, Petersen RC, Grundman M, Jin S, Gamst A, Ward CP, Sencakova D, Doody RS, and Thal LJ, for the Alzheimer’s Disease Cooperative Study Group (incl. Ahern GL). Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiology of Aging, 2008, 29, 1285-1295.

  16. Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, and Cummings JL, for the Alzheimer’s Disease Cooperative Study Group (incl. Ahern GL). Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology, 2009, 72, 2115-2121.

  17. Whitehair D C, Sherzi A, Emond J, Raman R, Aisen PS, Petersen RC,and  Fleisher AS, for the Alzheimer’s Disease Cooperative Study Group (incl. Ahern GL). Influence of apolipoprotein E e4 on rates of cognitive and functional decline in mild cognitive impairment. Alzheimer’s & Dementia, 2010, 6(5), 412-419.

  18. Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR, Weiner MW, Thomas RG, Schneider LS, and Tariot PN, for the Alzheimer’s Disease Cooperative Study Group (incl. Ahern GL). Chronic divalproex sodium use and brain atrophy in Alzheimer disease. Neurology, 2011, 77(13), 1263-1271.

  19. Fleisher AS, Chen K, Liu X, Roontiva A, Thiyyagura P, Ayutyanont N, Joshi AD, Clark CM, Mintun MA, Pontecorvo MJ, Doraiswamy PM, Johnson KA, Skovronsky DM, and Reiman EM, for the AV45-A11 Study Group (incl. Ahern GL). Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Archives of Neurology, 2011, 68(11), 1404-1411.

  20. Sano M, Bell KL, Galasko D, Galvin JE, Thomas RG, van Dyck CH, and Aisen PS, for the Alzheimer’s Disease Cooperative Study Group (incl. Ahern GL). A randomized, double-blind, placebo-controlled trial o. simvastatin to treat Alzheimer disease. Neurology, 2011, 77, 556-563.

  21. Tariot PN, Schneider LS, Cummings JL, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher AS, Ismail MS, Porteinsson A, Weiner M, Jack CR, Thal LJ, and Aisen PS, for the Alzheimer’s Disease Cooperative Study Group (incl. Ahern GL). Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease. Arch Gen Psychiatry, 2011, 68(8), 853-861.

  22. Doraiswamy PM, Sperling RA, Coleman RE, Johnson KA, Reiman EM, Davis MD, Grundman M, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Clark CM, Joshi AD, Mintun MA, Skovronsky DM, and Pontecorvo MJ, for the AV45-A11 Study Group (incl. Ahern GL). Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study. Neurology, 2012, 79 (), xxx-xxx.

Abstracts:

  1. Babikian VL, Araki C, Ahern GL, Norrving B, and Pochay VE. The delta-middle cerebral artery flow velocity. An index of extracranial carotid artery stenosis severity. Journal of Cardiovascular Technology, 1989, 8, 162-163.
  2. Babikian VL, Norrving B, Pochay VE, Araki C, and Ahern GL. Intracranial hemodynamic effects of cervical carotid artery disease evaluated by transcranial doppler. Neurology, 1989, 39 (suppl. 1), 217.
  3. Oommen KJ, Patton D, Fenstermacher W, Seeger J, Carter LP, Weinand ME, Labiner DM, Ahern GL, Herring A, Tackenberg J, and Martynec C. Comparison of SPECT and MRI foci to EEG foci in patients with complex partial seizures. Neurology, 1992, 42 (suppl. 3), 157.
  4. Weinand ME, Carter LP, Oommen KJ, Labiner DM, Patton D, Ahern GL, and Herring A. Surface monitoring of cerebral cortical blood flow in epilepsy. Neurology, 1992, 42 (suppl. 3), 158.
  5. Weinand ME, Wyler AR, Carter LP, Oommen KJ, Labiner DM, Ahern GL, Hermann BP, and Herring AM. Long-term subdural strip electrocorticographic monitoring of ictal deja vu. Epilepsia, 1992, 33 (suppl. 3), 95-96.
  6. Weintraub SW, Ahern GL, Daffner, KR, Price BH, and Mesulam MM. Right-sided hemispatial neglect. Neurology, 1992, 42 (suppl. 3), 223. (Abstract)
  7. Labiner DM, Weinand ME, Ahern GL, Oommen KJ, Carter LP, Patton DD, and Herring AM. Concordance between noninvasive and invasive evaluation techniques in seizure focus localization. Epilepsia, 1992, 33 (suppl. 3), 91.
  8. Hutzler R, Oommen KJ, Ahern GL, Weinand M, Carter LP, Labiner D, and Talwar D. Cerebral blood flow during hyperventilation in epileptic and non-epileptic temporal cortex. Epilepsia, 1993, 34 (suppl. 6), 77.
  9. Labiner DM, Ahern GL, Kolb MA, Johnson DS, and Vengrow MI. Gabapentin is both safe and effective in treating seizures associated with porphyria. Epilepsia, 1994, 35 (suppl. 8), 53.
  10. Weinand ME, Carter LP, Oommen KJ, Hutzler R, Labiner DM, Talwar D, El-Saadany W, and Ahern GL. Response of human epileptic temporal lobe cortical blood flow to hyperventilation. Epilepsia, 1995, 36 (suppl. 4), 141.
  11. Labiner DM, Ahern GL. Meta-analysis of vagus nerve stimulation in treating medically refractory epilepsy. Epilepsia, 1997, 38 (suppl. 8), 108.
  12. Labiner DM, Schwirtz D, Ahern GL, MacDonald J, and Weinand ME. Shorter pulse width of vagal nerve stimulation is as effective in reducing seizure frequency as standard stimulation and is better tolerated. Epilepsia, 1999, 60 (suppl. 7), 141.
  13. Ahern GL, Sollers J, and Thayer J. Heart rate and heart rate variability changes in the intracarotid sodium amytal test. Neurology, 2000, 54 (suppl. 3), A227.
  14. Lane RD, Katsanis J, Nielsen L, Ahern GL, Kaszniak A. Absence of conscious emotional experiences in a woman with observable emotional responses. Psychophysiology, 2000, 77, s74.
  15. Lane RD, Reiman EM, Ahern GL, Thayer JF.  Activity in medial prefrontal cortex correlates with vagal component of heart rate variability during emotion. Psychosomatic Medicine, 2000, 62, 1286.
  16. Lane RD, Reiman EM, Ahern GL, Thayer JF. Activity in medial prefrontal cortex correlates with vagal component of heart rate variability during emotion. Brain and Cognition, 2001, 47, 97-100.
  17. Lane RD, McRae K, Reiman EM, Ahern GL, Thayer JF. Neural correlates of vagal tone during emotion. Psychosomatic Medicine, 2007, 69, A-8.

Book Chapters:

  1. Ahern GL, Daffner KR, Duffy JD, and Mesulam MM. Selected Topics in Behavioral Neurology. In Jenike MA and Hyman S (Eds.), Manual of Clinical Problems in Psychiatry. Boston, Little Brown, 1990, pgs. 111-119.
  2. Ahern GL. Acute Behavior Change. In Green HL, Johnson WP, and Maricic MJ (Eds.), Decision Making in Internal Medicine. Toronto, BC Decker, 1993, pgs. 342-343.
  3. Ahern GL. Chronic Behavior Change. In Green HL, Johnson WP, and Maricic MJ (Eds.), Decision Making in Internal Medicine. Toronto, BC Decker, 1993, pgs. 344-347.
  4. Ahern GL. Coma. In Green HL, Johnson WP, and Maricic MJ (Eds.), Decision Making in Internal Medicine. Toronto, BC Decker, 1993, pgs. 354-355.
  5. Ahern GL. Memory Loss. In Green HL, Johnson WP, and Maricic MJ (Eds.), Decision Making in Internal Medicine. Toronto, BC Decker, 1993, pgs. 312-315.
  6. Reiman EM, Lane RD, Ahern GL, Schwartz GE, and Davidson RJ. Positron Emission Tomography, Emotion, and Consciousness. In Hameroff SR, Kaszniak AW, and Scott AC (Eds.), Toward A Science of Consciousness: The First Tucson Discussions and Debates. Boston, MIT Press, 1996, pgs. 311-320.
  7. Ahern GL. Acute Behavior Change. In Green HL, Johnson WP, and Lemcke D (Eds.), Decision Making in Internal Medicine, 2nd Ed. St. Louis, Mosby, 1998, pgs. 376-377.
  8. Ahern GL. Chronic Behavior Change. In Green HL, Johnson WP, and Lemcke D (Eds.), Decision Making in Internal Medicine, 2nd Ed. St. Louis, Mosby, 1998, pgs. 378-381.
  9. Ahern GL. Coma. In Green HL, Johnson WP, and Lemcke D (Eds.), Decision Making in Internal Medicine, 2nd Ed. St. Louis, Mosby, 1998, pgs. 384-385.
  10. Ahern GL. Memory Loss. In Green HL, Johnson WP, and Lemcke D (Eds.), Decision Making in Internal Medicine, 2nd Ed. St. Louis, Mosby, 1998, pgs. 344-347.
  11. Reiman EM, Lane RD, Ahern GL, Schwartz GE, and Davidson RJ. Positron Emission Tomography in the Study of Emotion, Anxiety, and Anxiety Disorders. In Lane RD, Nadel L, Ahern GL, Allen JB, Kaszniak AW, Rapcsak SZ, and Schwartz GE (Eds.), Cognitive Neuroscience of Emotion. New York, Oxford University Press, 2000, pgs. 389-406.

Books (Author/Editor):

  1. Lane RD, Nadel L, Ahern GL, Allen JB, Kaszniak AW, Rapcsak SZ, and Schwartz GE (Eds.), Cognitive Neuroscience of Emotion. New York, Oxford University Press, 2000.

Conference Proceedings / Scholarly Presentations:

  1. Jabre JF, Bauermeister W, Gan R, and Ahern GL. Relationships of various motor unit potential parameters to motor unit size. Presented at the American Association of EMG and Electrodiagnosis Annual Meeting in San Diego, CA, October 5-8, 1988.
  2. Turkstra LS and Ahern GL. Electrodermal response and outcome from post-traumatic vegetative state. Presented at the 11th Annual Neurotrauma Society Meeting in Washington, DC, November 11, 1993.
  3. Reiman EM, Lane RD, Ahern GL, Schwartz GE, Davidson RJ, and Yun LS. Neuroanatomical correlates of normal human emotion. Presented at the Society for Neuroscience Meeting, Washington, DC, November, 1993.
  4. Ahern GL, Herring AM, Tackenberg JN, Schwartz GE, Seeger JF, Labiner DM, Weinand ME, and Oommen KJ. Affective self-report during the intracarotid sodium amobarbital test. Presented at the International Neuropsychological Society Meeting, Cincinnati, OH, February 2-5, 1994.
  5. Lane RD, Reiman EM, Ahern GL, Schwartz GE, Davidson RJ, and Axelrod B. Neuroanatomical correlates of normal human emotion. Presented at the Annual Meeting of the American Psychosomatic Society in Boston, MA, April, 1994.
  6. Lane RD, Reiman EM, Ahern GL, Schwartz GE, Davidson RJ, and Axelrod B. Neuroanatomical correlates of normal human emotion. Presented at the American Psychiatric Association Meeting in Philadelphia, PA, May 21-26, 1994.
  7. Lane RD, Reiman EM, Ahern GL, Schwartz GE, Davidson RJ, and Axelrod B. Neuroanatomical correlates of normal human emotion. Presented at the Annual Meeting of the International Society for Research on Emotion in Cambridge, England, July, 1994.
  8. Weinand ME, El-Saadany W, Carter LP, Labiner DM, Oommen KJ, Talwar D, and Ahern GL. Temporal lobe ischemia and epileptogenicity: Long-term cortical cerebral blood flow analysis of sequential seizures. Presented at the Neurosurgical section of the Annual American College of Surgeons Meeting, New Orleans, LA., October 22-26, 1995.
  9. Labiner DM, McGregor T, Ahern GL, and Bell S. The cost of epilepsy in Yuma county, Arizona. Presented at the American Epilepsy Society Annual Meeting, Baltimore, MD., December 5, 1995.
  10. Weinand ME, El-Saadany W, Labiner DM, Talwar D, and Ahern GL. Subdural strip electrode monitoring and surgical decision making in refractory epilepsy. Validity and prognostic value of noninvasive localizing data. Presented at the 41st Annual Meeting, The Western Neurosurgical Society, Gleneden Beach, OR, September 9-12, 1995.
  11. Lane RD, Reiman EM, Ahern GL, Schwartz GE, and Davidson RJ. Neuroanatomical correlates of happiness, sadness, and disgust. Presented at the First International Conference on Functional Mapping of the Human Brain, Paris, June 26-30, 1995.
  12. Lane RD, Reiman EM, Ahern GL, Schwartz GE, Davidson RJ, Axelrod B, and Yun L. Anterior cingulate cortex participates in the conscious experience of emotion. Presented at the 54th Annual Meeting of the American Psychosomatic Society, Williamsburgh, VA, March 7-10, 1996.
  13. Lane RD, Reiman EM, Ahern GL, Schwartz GE, and Davidson RJ. Neuroanatomical correlates of happiness, sadness, and disgust. Presented at the 54th Annual Meeting of the American Psychosomatic Society, Williamsburgh, VA, March 7-10, 1996.
  14. Lane RD, Reiman EM, Bradley MM, Lang PJ, Ahern GL, Davidson RJ, and Schwartz GE. Neuroanatomical correlates of positive and negative emotion. Presented at the Annual Meeting of the Society for Neuroscience, Washington, D.C., November 16-21, 1996.
  15. Ahern GL, Herring AM, Labiner DM, and Weinand ME. Quantification of hemispatial neglect during the intracarotid amytal procedure. Presented at the 25th Annual Meeting of the International Neuropsychological Society, Orlando, FL, February 5-8, 1997.
  16. Labiner DM and Ahern GL. A meta-analysis of vagus nerve stimulation in treating medically refractory epilepsy. Presented at the American Epilepsy Society Annual Meeting, Boston, MA., December 7-10, 1997.
  17. Reminger SL, Herring AM, Ahern GL, Weinand ME, and Labiner DM. The utility of neuropsychological test measures in the prediction of seizure lateralization in temporal lobe epilepsy. Presented at the 26th Annual Meeting of the International Neuropsychological Society, Honolulu, HI, February 4-7, 1998.
  18. Lane RD, Reiman EM, Ahern GL, and Thayer JF. Activity in medial prefrontal cortex correlates with vagal component of heart rate variability during emotion. Presented at the Annual Meeting of the Society for Neuroscience, Miami, FL, October 24, 1999.
  19. Labiner DM, Schwirtz D, Ahern GL, MacDonald J, Weinand ME. Shorter pulse width of vagal nerve stimulation is as effective in reducing seizure frequency as standard stimulation and is better tolerated. Presented at the Annual Meeting of the American Epilepsy Society, Orlando, FL, December 3-8, 1999.
  20. Ahern GL, Sollers J, and Thayer J. Heart rate and heart rate variability changes in the intracarotid sodium amytal test. Presented at the 52nd Annual Meeting of the American Academy of Neurology, San Diego, CA, April 29 - May 6, 2000.

  21. Lane RD, Katsanis J, Nielsen L, Ahern GL, Kaszniak A. Absence of conscious emotional experiences in a woman with observable emotional responses. Presented at Tucson IV: Toward a Science of Consciousness. Tucson, AZ, April, 2000.
  22. Sollers J, Ahern GL, and Thayer J. Heart rate and heart period variability changes in the intracarotid sodium amytal test. Presented at the 40th Annual Meeting of the Society for Psychophysiological Research, San Diego, CA, October 18-22, 2000.
  23. Lane RD, Katsanis J, Nielsen L, Ahern GL, Kaszniak A. Absence of conscious emotional experiences in a woman with observable emotional responses. Presented at Annual Meeting of the Society for Psychophysiological Research, San Diego, CA, October, 2000.
  24. Weinand ME, Hassan M, Ahern GL, and Labiner DM. Invasive versus noninvasive selection of temporal lobectomy candidates. Presented at the 51st Annual Meeting of the Congress of Neurological Surgeons, San Diego, CA, September 29 – October 4, 2001.
  25. Weinand ME, Labiner DM, and Ahern GL. Prognostic value of concordant localizing data in the selection of temporal lobectomy candidates. Presented at the Annual Meeting of the Western Neurosurgical Society, Victoria, British Columbia, September 15 – 18, 2001.
  26. Kawarai T, Rogaeva E, Song YQ, Moliaka Y, Medeiros H, Liang Y, Sato C, Ling S, Fong M, Kolesnikova T, Bergeron C, Lang AE, St. George-Hyslop P, Paterson AD, Orlacchio A, Bernardi G, Rockwood K, Allegri R, Rainero E, Pinessi E, Kertesz A, Bruni A, Freedman M, Ahern GL, Tuite P, and Fornazzari L. Low frequency of tau mutations and further genetic heterogeneity in FTD. Presented at the 8th Annual International Alzheimer’s Disease Conference, Stockholm, Sweden, July 20 – 25, 2002.
  27. Aisen PS, Schafer K, Grundman M, Farlow M, Sano M, Jin S, Thomas R, Thal L, and the Alzheimer’s Disease Cooperative Study (incl. Ahern GL). Results of multicenter trial of rofecoxib and naproxen in Alzheimer’s Disease. Presented at the 8th Annual International Alzheimer’s Disease Conference, Stockholm, Sweden, July 20 – 25, 2002.
  28. Alexander GE, Wheeler-Rice L, Zhuang Y, Connor DJ, Sabbagh M, Baxter LC, Ahern GL, Herring A, Rapcsak S, Comer J, Shi J, Reyes PF, Woodruff B, Osborne D. Reiman EM, Caselli RJ, for the Arizona Alzheimer’s Disease Consortium. Individual differences in attentional performance predict verbal learning in healthy elderly. Presented at the Arizona Alzheimer’s Research Center 2005 Annual Meeting, Phoenix, AZ, April 22-23, 2005.
  29. Wheeler-Rice L, Alexander GE, Zhuang Y, Connor DJ, Sabbagh M, Baxter LC, Ahern GL, Herring A, Rapcsak S, Comer J, Shi J, Reyes PF, Woodruff B, Osborne D, Reiman EM, Caselli RJ. Individual differences in attentional performance predict verbal learning in healthy elderly. Presented at the 35th Annual Meeting of the Society for Neuroscience, Washington, D.C., November 12-16, 2005.
  30. Rapcsak SZ, Henry ML, Beeson PM, Baxter L, Ahern GL, Caselli RJ, for the Arizona Alzheimer’s Disease Consortium. Written language processing in individuals with semantic dementia versus left posterior cerebral artery stroke: similarities and differences. Presented at the World Federation of Neurology Aphasia and Cognitive Disorders Research Group, Buenos Aires, Argentina, March 1-4, 2006.
  31. Lane RD, McRae K, Reiman EM, Ahern GL, Thayer JF. Neural correlates of vagal tone during emotion. Presented at the 64th Annual Meeting of the American Psychosomatic Society, Denver, CO, March 1-4, 2006.
  32. Lane RD, McRae K, Reiman EM, Ahern GL, Thayer JF.  Neural correlates of vagal tone during emotion. Presented at the 65th Annual Meeting of the American Psychosomatic Society Meeting, Budapest, Hungary, March 7-10, 2007.
  33. Caselli RJ, Hentz JG, Osborne D, Sabbagh M, Connor D, Ahern G, Baxter L, Rapcsak S, Hutton MF, Reiman EM. Apolipoprotein E (APOE) e4 Selectively Accelerates Age-Related Memory Decline. Presented at the 60th Annual Meeting of the American Academy of Neurology, Chicago, IL, April 12-19, 2008.
  34. Caselli RJ, Dueck AC, Locke DEC, Sabbagh MN, Ahern GL, Baxter LC, Rapcsak SZ, Yaari R, Woodruff BK BK, Hoffman-Snyder C, Findley S, Reiman EM. Cerebrovascular Risk Factors Influence Age-Related Memory Decline. Presented at the 62nd Annual Meeting of the American Academy of Neurology, Toronto, Ontario, April 10–17, 2010.
  35. Alexander GE, Hanson KD, Bergfield KL, Hishaw GA, Bowen TA, Vargas IM, Lin L, Valfre ME, Aiken LS, Luecken LJ, Chen K, Reiman EM, Ahern GL, Huentelman MJ, Trouard TP, Moeller JR. Impact of hypertension and aerobic fitness on brain and cognitive aging: a network analysis of MRI gray matter in healthy late middle-aged and older adults.  Presented at the Arizona Alzheimer’s Consortium Annual Scientific Conference, Phoenix, AZ, June 10, 2011.
  36. Varteresian T, Langbaum JB, Reeder S, Hamilton E, Lalio F, Dougherty J, Rapcsak S, Shi J, Baxter L, Ahern GL, Brand H, Woodruff BK, Caselli RJ, Sabbagh M, Tariot PN, Reiman EM, Yaari Y. Evaluating depression in older Native Americans.  Presented at the American Association for Geriatric Psychiatry, Washington, DC, March 16-19, 2012.